Connor, Clark & Lunn Investment Management Ltd. Aldeyra Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$7.11 - $11.89 $97,862 - $163,653	-13,764 Reduced 7.52%	169,306 $1.42 Million
Q1 2023 May 09, 2023	SELL	$5.77 - $9.93 $10,524 - $18,112	-1,824 Reduced 0.99%	183,070 $1.82 Million
Q4 2022 Feb 10, 2023	SELL	$5.08 - $7.09 $209,819 - $292,838	-41,303 Reduced 18.26%	184,894 $1.29 Million
Q3 2022 Nov 10, 2022	BUY	$3.8 - $7.74 $601,475 - $1.23 Million	158,283 Added 233.06%	226,197 $1.21 Million
Q2 2022 Aug 05, 2022	BUY	$2.43 - $4.85 $165,031 - $329,382	67,914 New	67,914 $271,000
Q3 2020 Nov 12, 2020	SELL	$4.0 - $7.53 $65,384 - $123,085	-16,346 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$1.97 - $5.05 $164,250 - $421,048	-83,376 Reduced 83.61%	16,346 $68,000
Q1 2020 May 13, 2020	BUY	$1.62 - $6.4 $16,564 - $65,440	10,225 Added 11.42%	99,722 $246,000
Q4 2019 Feb 12, 2020	BUY	$4.73 - $7.98 $58,297 - $98,353	12,325 Added 15.97%	89,497 $520,000
Q3 2019 Nov 13, 2019	SELL	$4.41 - $6.12 $82,409 - $114,364	-18,687 Reduced 19.49%	77,172 $407,000
Q2 2019 Aug 07, 2019	BUY	$6.0 - $9.0 $82,650 - $123,975	13,775 Added 16.78%	95,859 $575,000
Q1 2019 May 08, 2019	BUY	$7.14 - $9.85 $249,214 - $343,804	34,904 Added 73.98%	82,084 $741,000
Q4 2018 Feb 12, 2019	BUY	$7.26 - $13.29 $342,526 - $627,022	47,180 New	47,180 $392,000

Others Institutions Holding ALDX

# of Institutions

117

Shares Held

36.4M

Call Options Held

196K

Put Options Held

142K

Perceptive Advisors LLC New York, NY

9.28M
Shares

$45 Million
1.31% of portfolio
Knoll Capital Management, LLC Miami, FL

5.48M
Shares

$26.6 Million
14.56% of portfolio
Vanguard Group Inc Valley Forge, PA

3.76M
Shares

$18.2 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.62M
Shares

$17.6 Million
0.0% of portfolio
Kennedy Capital Management, Inc. St Louis, MO

1.88M
Shares

$9.12 Million
0.24% of portfolio

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $283M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account